H Serve Selected Research

H Serve Research Topics

Disease

18	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018 - 12/2000
12	Neoplasms (Cancer) 03/2013 - 04/2000
6	Leukemia 01/2017 - 09/2003
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2020 - 07/2012
3	Residual Neoplasm 07/2020 - 06/2013
2	Acute Promyelocytic Leukemia 12/2009 - 12/2000
2	Stomach Neoplasms (Stomach Cancer) 09/2006 - 06/2006
2	Hematologic Neoplasms (Hematological Malignancy) 09/2003 - 07/2002
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2001 - 01/2001
1	Pathologic Complete Response 01/2018
1	Splenomegaly 03/2016
1	Hemorrhage 03/2016
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2016
1	Infections 08/2013
1	Philadelphia Chromosome 07/2012
1	Cardiotoxicity 04/2012
1	Adenocarcinoma 09/2006
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2002
1	Neoplasm Metastasis (Metastasis) 01/2001
1	Myeloid Leukemia (Leukemia, Myelocytic) 12/2000
1	Glioblastoma (Glioblastoma Multiforme) 09/2000
1	Glioma (Gliomas) 09/2000
1	Osteosarcoma (Osteogenic Sarcoma) 05/2000
1	Multiple Myeloma 04/2000

Drug/Important Bio-Agent (IBA)

4	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 09/2006 - 12/2000
4	Cyclin A1IBA 04/2001 - 05/2000
3	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2018 - 12/2009
3	Imatinib Mesylate (Gleevec)FDA Link 06/2013 - 06/2006
3	Phosphotransferases (Kinase)IBA 07/2012 - 06/2006
3	Proteins (Proteins, Gene)FDA Link 01/2004 - 12/2000
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 07/2020 - 01/2019
2	tyrosine receptor (receptor, tyrosine)IBA 08/2007 - 06/2006
2	ErbB Receptors (EGF Receptor)IBA 09/2006 - 06/2006
2	Gefitinib (Iressa)FDA Link 09/2006 - 06/2006
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2002 - 04/2000
2	CyclinsIBA 01/2001 - 12/2000
1	Amsacrine (AMSA)IBA 01/2018
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2018
1	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2018
1	PlasticsIBA 01/2017
1	DNA Methyltransferase 3AIBA 01/2017
1	Heparin (Liquaemin)FDA LinkGeneric 03/2016
1	Azacitidine (5 Azacytidine)FDA Link 03/2016
1	fms-Like Tyrosine Kinase 3IBA 02/2016
1	fludarabineIBA 05/2014
1	quizartinibIBA 03/2014
1	Ribavirin (Virazole)FDA LinkGeneric 08/2013
1	Gemtuzumab (Mylotarg)FDA Link 04/2012
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2009
1	AnthracyclinesIBA 03/2008
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2008
1	Transcription Factors (Transcription Factor)IBA 08/2007
1	Retinoic Acid Receptor alphaIBA 08/2007
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2006
1	Bevacizumab (Avastin)FDA Link 06/2006
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 06/2006
1	Trastuzumab (Herceptin)FDA Link 06/2006
1	Cetuximab (Erbitux)FDA Link 06/2006
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 04/2004
1	Messenger RNA (mRNA)IBA 04/2004
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 09/2003
1	Constitutive Androstane ReceptorIBA 09/2003
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2003
1	Growth Factor ReceptorsIBA 10/2002
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 07/2002
1	Ifosfamide FDA LinkGeneric 01/2002
1	Etoposide (VP 16)FDA LinkGeneric 01/2002
1	Carboplatin (JM8)FDA LinkGeneric 01/2002
1	Cyclin AIBA 01/2001
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2001
1	Cyclin EIBA 01/2001
1	Cyclin A2IBA 01/2001
1	Oncostatin MIBA 09/2000
1	Mitogen-Activated Protein KinasesIBA 09/2000
1	Glial Fibrillary Acidic ProteinIBA 09/2000
1	enhanced green fluorescent proteinIBA 05/2000
1	Interleukin-6 (Interleukin 6)IBA 04/2000
1	CytokinesIBA 04/2000

Therapy/Procedure

6	Therapeutics 01/2016 - 01/2002
3	Induction Chemotherapy 03/2016 - 12/2009
3	Drug Therapy (Chemotherapy) 01/2016 - 03/2008
2	Cell Transplantation 11/2017 - 05/2015
1	Hematopoietic Stem Cell Transplantation 05/2015
1	Stem Cell Transplantation 06/2013
1	Complementary Therapies (Alternative Medicine) 03/2013